Modeling Nonalcoholic Fatty Liver Disease in the Dish Using Human-Specific Platforms: Strategies and Limitations

被引：11
|
作者：
Rezvani, Milad [1 ,2 ,3 ,4 ]
Vallier, Ludovic [3 ,5 ]
Guillot, Adrien [6 ,7 ,8 ,9 ]
机构：
[1] Charite Univ Med Berlin, Dept Pediat Gastroenterol Nephrol & Metab Med, Berlin, Germany
[2] Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH USA
[3] Berlin Inst Hlth, Ctr Regenerat Therapies BCRT, Berlin, Germany
[4] Berlin Inst Hlth, Clinician Sci Program, Berlin, Germany
[5] Max Planck Inst Mol Genet, Berlin, Germany
[6] Charite Univ Med Berlin, Campus Virchow Klinikum, Berlin, Germany
[7] Campus Charite Mitte, Dept Hepatol & Gastroenterol, Berlin, Germany
[8] Charite Univ Med Berlin, Campus Virchow Klinikum, D-13353 Berlin, Germany
[9] Campus Charite Mitte, Dept Hepatol & Gastroenterol, D-13353 Berlin, Germany
来源：
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY | 2023年 / 15卷 / 05期
关键词：
Induced Pluripotent Stem Cells; Liver-on-Chip; Precision-Cut Liver Slices; Liver Organoids; PLURIPOTENT STEM-CELLS; PRECISION-CUT LIVER; CHOLANGIOCYTE ORGANOIDS; GENE-EXPRESSION; HEPATOCYTES; GENERATION; METABOLISM; EPITHELIUM; SLICES; MOUSE;
D O I：
10.1016/j.jcmgh.2023.01.014
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
This review article presents the latest research on nonal-coholic fatty liver disease (NAFLD) in vitro modeling. Ben-efits and limitations of using human induced pluripotent stem cell-derived approaches, primary organoids, liver-on-a-chip, and precision-cut liver sections are discussed to help researchers choose the most appropriate model.
引用
收藏
页码：1135 / 1145
页数：11
相关论文
共 50 条
  • [21] Nonalcoholic fatty liver disease: current concepts, epidemiology and management strategies
    Tomic, Dunya
    Kemp, William W.
    Roberts, Stuart K.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (10) : 1103 - 1115
  • [22] New therapeutic strategies in nonalcoholic fatty liver disease: a focus on promising drugs for nonalcoholic steatohepatitis
    Natalia Pydyn
    Katarzyna Miękus
    Jolanta Jura
    Jerzy Kotlinowski
    Pharmacological Reports, 2020, 72 : 1 - 12
  • [23] New therapeutic strategies in nonalcoholic fatty liver disease: a focus on promising drugs for nonalcoholic steatohepatitis
    Pydyn, Natalia
    Miekus, Katarzyna
    Jura, Jolanta
    Kotlinowski, Jerzy
    PHARMACOLOGICAL REPORTS, 2020, 72 (01) : 1 - 12
  • [24] Transcriptional networks implicated in human nonalcoholic fatty liver disease
    Hua Ye
    Wei Liu
    Molecular Genetics and Genomics, 2015, 290 : 1793 - 1804
  • [25] Transcriptional networks implicated in human nonalcoholic fatty liver disease
    Ye, Hua
    Liu, Wei
    MOLECULAR GENETICS AND GENOMICS, 2015, 290 (05) : 1793 - 1804
  • [26] Metabolomic classification of murine and human nonalcoholic fatty liver disease
    Alonso, Cristina
    Lavine, Jose L.
    Iruarrizaga-Lejarreta, Marta
    Fernandez, David
    van Liempd, Sebastiaan
    delaCruz-Villar, Laura
    Navasa, Nicolas
    Martinez-Arranz, Ibon
    Aurrecoechea, Igor
    Buque, Xavier
    Varela, Marta
    Falcon-Perez, Juan M.
    Newberry, Elizabeth P.
    Aspichueta, Patricia
    Aransay, Ana M.
    Noureddin, Mazen
    Anguita, Juan
    Davidson, Nicholas O.
    Martinez-Chantar, Maria L.
    Lu, Shelly C.
    Mato, Jose M.
    HEPATOLOGY, 2016, 64 : 794A - 795A
  • [27] Is there a role for neuregulin 4 in human nonalcoholic fatty liver disease?
    De Munck, Toon J. I.
    Boesch, Markus
    Verhaegh, Pauline
    Masclee, Ad A. M.
    Jonkers, Daisy
    van Pelt, Jos F.
    du Plessis, Johannie
    Korf, Hannelie
    Nevens, Frederik
    Koek, Ger H.
    Van der Merwe, Schalk
    Verbeek, Jef
    PLOS ONE, 2021, 16 (05):
  • [28] Activation of the Complement System in Human Nonalcoholic Fatty Liver Disease
    Rensen, Sander S.
    Slaats, Yanti
    Driessen, Ann
    Peutz-Kootstra, Carine J.
    Nijhuis, Jeroen
    Steffensen, Rudi
    Greve, Jan Willem
    Buurman, Wim A.
    HEPATOLOGY, 2009, 50 (06) : 1809 - 1817
  • [29] FURTHER UNDERSTANDING THE SIGNIFICANCE OF SPECIFIC AUTOANTIBODIES IN NONALCOHOLIC FATTY LIVER DISEASE
    Shroff, Puneet
    Sussman, Norman L.
    Jalal, Prasun K.
    HEPATOLOGY, 2008, 48 (04) : 524A - 524A
  • [30] Nonalcoholic Fatty Liver Disease Natural History: Role of Mathematical Modeling
    Chhatwal, Jagpreet
    Tapper, Elliot B.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (02) : 280 - 282
12345